Crinetics Pharmaceuticals SG&A Expenses 2017-2024 | CRNX

Crinetics Pharmaceuticals sg&a expenses for the twelve months ending September 30, 2024 were $0.089B, a 69.51% increase year-over-year.

  • Crinetics Pharmaceuticals annual sg&a expenses for 2023 were $0.058B, a 37.03% increase from 2022.
  • Crinetics Pharmaceuticals annual sg&a expenses for 2022 were $0.042B, a 72.86% increase from 2021.
  • Crinetics Pharmaceuticals annual sg&a expenses for 2021 were $0.025B, a 36.05% increase from 2020.

Crinetics Pharmaceuticals SG&A Expenses 2017-2024 | CRNX

  • Crinetics Pharmaceuticals annual sg&a expenses for 2023 were $0.058B, a 37.03% increase from 2022.
  • Crinetics Pharmaceuticals annual sg&a expenses for 2022 were $0.042B, a 72.86% increase from 2021.
  • Crinetics Pharmaceuticals annual sg&a expenses for 2021 were $0.025B, a 36.05% increase from 2020.